COFEPRIS-2021-0034-V134

Major variation for application COFEPRIS-2021-0034. Major variation: Formulation Change for Glucovantib — major revision

Variation Number
COFEPRIS-2021-0034-V134
Type
Major
Application
COFEPRIS-2021-0034
Change
CHG-2023-0134
Status
Completed
Fee
€60,617
Submitted
2024-03-06
Approved
—
Description

Major variation: Formulation Change for Glucovantib — major revision